XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 93 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,493,971 | -29.0% | 5,641,920 | 0.0% | 39.87% | -6.5% |
| Q2 2023 | $14,781,830 | +50.2% | 5,641,920 | -6.6% | 42.66% | +71.6% |
| Q1 2023 | $9,843,616 | +22.6% | 6,039,028 | 0.0% | 24.86% | +21.2% |
| Q4 2022 | $8,031,907 | -14.7% | 6,039,028 | 0.0% | 20.52% | +15.8% |
| Q3 2022 | $9,421,000 | +1.3% | 6,039,028 | 0.0% | 17.72% | +41.8% |
| Q2 2022 | $9,300,000 | -39.8% | 6,039,028 | 0.0% | 12.49% | -35.0% |
| Q1 2022 | $15,460,000 | -16.4% | 6,039,028 | -4.3% | 19.22% | +27.2% |
| Q4 2021 | $18,490,000 | – | 6,310,546 | – | 15.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,641,920 | $14,781,830 | 42.66% |
| Stonepine Capital Management, LLC | 5,500,228 | $14,410,597 | 5.20% |
| MPM BioImpact LLC | 3,974,999 | $10,414,497 | 2.10% |
| Soleus Capital Management, L.P. | 2,054,105 | $5,381,755 | 0.60% |
| EAM Investors, LLC | 757,962 | $1,985,860 | 0.37% |
| DELTEC ASSET MANAGEMENT LLC | 406,190 | $1,064,218 | 0.23% |
| Alpine Global Management, LLC | 225,000 | $589,500 | 0.18% |
| Redmile Group, LLC | 1,046,587 | $2,742,058 | 0.10% |
| IHT Wealth Management, LLC | 281,442 | $737,379 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 127,091 | $332,978 | 0.04% |